1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 193 pages

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
B-Cell Lymphomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of B-Cell Lymphomas 25
Subjects Recruited Over a Period of Time 38
Clinical Trials by Sponsor Type 39
Prominent Sponsors 40
Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials 41
Prominent Drugs 43
Latest Clinical Trials News on B-Cell Lymphomas 44
Jan 29, 2014: Cancer Research UK launches trial of new lymphoma treatment 44
Dec 10, 2013: Senesco's Drug Candidate SNS01-T Selectively Kills Cancer Cells and Not Healthy Cells in Disease Models 44
Dec 06, 2013: Rhizen Pharmaceuticals announces initiation of a “First in Human” Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies 45
Dec 06, 2013: TG Therapeutics Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies 45
Jun 19, 2013: Senesco Announces Results Of Cohort 2 Of Its SNS01-T Phase Ib/IIa Trial 46
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Celgene Corporation 55
Clinical Trial Overview of Celgene Corporation 55
Takeda Pharmaceutical Company Limited 60
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 60
GlaxoSmithKline plc 64
Clinical Trial Overview of GlaxoSmithKline plc 64
Novartis AG 68
Clinical Trial Overview of Novartis AG 68
Biogen Idec Inc. 71
Clinical Trial Overview of Biogen Idec Inc. 71
Pfizer Inc. 74
Clinical Trial Overview of Pfizer Inc. 74
Pharmacyclics, Inc. 77
Clinical Trial Overview of Pharmacyclics, Inc. 77
Amgen Inc. 80
Clinical Trial Overview of Amgen Inc. 80
Janssen Global Services, LLC 83
Clinical Trial Overview of Janssen Global Services, LLC 83
Clinical Trial Overview of Top Institutes / Government 85
National Cancer Institute 85
Clinical Trial Overview of National Cancer Institute 85
Fred Hutchinson Cancer Research Center 97
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 97
The University of Texas M. D. Anderson Cancer Center 102
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 102
Memorial Sloan Kettering Cancer Center 105
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 105
Southwest Oncology Group 107
Clinical Trial Overview of Southwest Oncology Group 107
Groupe d'Etudes de Lymphomes de L'Adulte 109
Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte 109
Mayo Clinic 111
Clinical Trial Overview of Mayo Clinic 111
City of Hope National Medical Center 113
Clinical Trial Overview of City of Hope National Medical Center 113
Five Key Clinical Profiles 115
Appendix 190
Abbreviations 190
Definitions 190
Research Methodology 191
Secondary Research 191
About GlobalData 192
Contact Us 192
Disclaimer 192
Source 193

List of Tables
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014* 7
B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 15
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 18
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014* 21
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
B-Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014* 25
B-Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
B-Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014* 28
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 38
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 39
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 40
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 42
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 43
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 47
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 55
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 60
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 64
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 68
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 71
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 74
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014* 77
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 80
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 83
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 85
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 97
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 102
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 105
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 107
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2014* 109
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 111
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 113

List of Figures
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 15
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 18
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 38
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 39
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 40
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 41
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 43
GlobalData Methodology 191

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma o ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in the US and the UK

  • December 2016
    12 pages
  • Pathology  

    Digestive Syste...  

    Cancer  

  • United States  

    United Kingdom  

View report >

Pathology Statistics in the US and the UK

  • December 2016
    13 pages
  • Pathology  

    Digestive Syste...  

  • United States  

    United Kingdom  

View report >

Biological Therapy Industry - Forecast

  • December 2016
    13 pages
  • Cancer  

    Lymphoma  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.